1219130-47-8 Usage
Description
5-Bromo-8-methoxyquinazoline, a chemical compound with the molecular formula C9H7BrN2O, is a member of the quinazoline derivatives class. It is a brominated and methoxylated derivative of quinazoline, known for its potential interactions with biological targets. 5-BroMo-8-Methoxyquinazoline has garnered interest in medicinal chemistry research due to its unique chemical structure and pharmacological properties, which may contribute to the development of new drugs and therapeutic agents.
Uses
Used in Pharmaceutical Industry:
5-Bromo-8-methoxyquinazoline is used as a key intermediate in the synthesis of various drugs for its ability to interact with biological targets. Its unique chemical structure and potential pharmacological properties make it a promising candidate for the development of new therapeutic agents.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 5-Bromo-8-methoxyquinazoline is utilized as a research compound to explore its potential applications in drug discovery. Its interaction with biological targets and unique chemical properties allow researchers to investigate its efficacy in treating various diseases and conditions.
Further research and studies are necessary to fully understand the potential uses of 5-Bromo-8-methoxyquinazoline in medicine and other fields, as its applications may extend beyond the current scope of pharmaceutical synthesis and medicinal chemistry research.
Check Digit Verification of cas no
The CAS Registry Mumber 1219130-47-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,9,1,3 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1219130-47:
(9*1)+(8*2)+(7*1)+(6*9)+(5*1)+(4*3)+(3*0)+(2*4)+(1*7)=118
118 % 10 = 8
So 1219130-47-8 is a valid CAS Registry Number.
1219130-47-8Relevant articles and documents
CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
-
, (2018/03/09)
Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.
HETEROCYCLIC BIARYL DERIVATIVE AND PDE INHIBITOR COMPRISING SAME AS ACTIVE INGREDIENT
-
Page/Page column 28, (2011/08/04)
Novel heterocyclic biaryl derivatives were disclosed which are useful as pharmaceutical agents and which exhibit a phosphodiesterase-inhibitory action. The heterocyclic biaryl derivatives are represented by the following general formula (1): wherein the H
